Substitute for form 1449/PTO
`
`Complete if Known
`
`4387.0160001
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`
` First NamedInventor SCHWARZ; Tomas
`Art Unit
`3794
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`|
`| of
`1
`
`
`Examiner
`Initials*
`
`NaS
`
`Document Number
`
`Pages, Columns,Lines, Where
`Relevant Passages or Relevant
`Figures Appear
` Number-Kind Code?“kro“)
`
`U. S. PATENT DOCUMENTS
`Publication Date
`Nameof Patentee or
`MM-DD-YYYY
`Applicant of Cited Document
`
`WORTHINGTON; Arnold
`Vandoranus
`07-29-1913
`US-1068831-A
`US-11247063-B2|02-15-2022|SCHWARZ;Tomasetal.||
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner
`Initials*
`
`Foreign Patent Document
`
`Pages, Columns,Lines,
`Publication
`Where Relevant Passages
`Date
`Cit
`Or Relevant Figures Appear
`i
`MM-DD-YYYY
`Not
`Country Code*Number*Kind Code° (if known)
`
`Nameof Patentee or
`Applicant of Cited Document
`
`CA-2915928-A1
`
`12-24-2014
`
`UNIV MUENCHEN
`TECH [DE]
`
`STRAUBE
`DE-102007044445-A1 03-19-2009|ANDREAS[DE], et
`al.
`
`
`
`QUANTEN
`04-21-2011 MEDICINE AG[LI]
`DE-102009049145-A1
`
`MEDICAL DEVICE
`EP-2069014-A2 06-17-2009|INNOVATIONS
`
`
`
`ERON
`
`
`
`
`
`
`
`JP-2015208504-A 11-24-2015|MIZUNO KK.
`
`=GB-2176009-A 12-10-1986|VMEILENINNIS. |e
`
`JP-2018534028-A
`
`11-22-2018
`
`NIKE INNOVATE
`CV., et al.
`
`Examiner
`Signature
`
`Date
`Considered
`
`1
`2
`*EXAMINER: Initial if reference considered, whetheror notcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`3
`4
`considered. Include copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional). See Kinds Codes of USPTO Patent
`Documents at waw.uspto.goyor MPEP 901.04. Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. “Kind of document by the appropriate symbols as indicated on the
`document under WIPO Standard ST.16 if possible. * Applicant is to place a check markhereif English languageTranslation is attached.
`
`

`

`(Use as many sheets as necessary)
`
`
`Complete if Known
`Substitute for form 1449/PTO
`[ApplicationNumber_[17/151,389
`INFORMATION DISCLOSURE
`[FilingDate(01-18-2021
` STATEMENTBY APPLICANT FNRCHWARZ: Tomas
`3791
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`4387.0160001
`|
`| of
`2
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`
`
`
`
`
`
`Nameof Patentee or
`Examiner
`Foreign Patent Document
`Publication
`Pages, Columns,Lines,
`Applicant of Cited Document
`Initials*
`Date
`Where Relevant Passages
`
`
`
`
`MM-DD-YYYY Or Relevant Figures Appear
`
`
`
`MEDICAL
`
` WO-0230511-A2
`
` 04-18-2002|MAGNETICSSA010
`
`[ES], et al.
`
`Country Code*Number"Kind Code® (if known)
`
` Examiner
`
`Date
`Considered
`
`Signature
`
`1
`2
`*EXAMINER: Initial if reference considered, whetheror notcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`considered. Include copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional). See Kinds Codes of USPTO Patent
`
`5
`Documents at wr
`to.goyor MPEP 901.04. * Enter Office that issued the document, by the two-letter code (WIPO Standard ST.3). “For Japanese patent documents, the
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. Kind of document by the appropriate symbols as indicated on the
`document under WIPO Standard ST.16 if possible. * Applicant is to place a check markhereif English languageTranslation is attached.
`
`

`

`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`
`
`Complete if Known
`Application Number
`17/151,389
`Filing
`Dat
`[FilingDate01-18-2021
`
` First NamedInventor SCHWARZ; Tomas
`Art Unit
`3794
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`4387.0160001
`
`
`
`3
`
`| of
`
`|
`
`
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`i
`;
`
`Include name of the author(in CAPITAL LETTERS), title of the article(when appropriate), title of
`the item (book, magazine,journal,serial,symposium, catalog, etc. ), date, page(s), volume-issue
`number(s), publisher, city and/or country where published.
`
`European Commission, Neuodegenerative Disorders, 10 pages printed December 27, 2016.
`
`FDAletter to Venus Legacy, 2014-12-19, 7 pages.
`
`FinalOfficeAction mailed September12, 2016, in UnitedStatesPatentApplication No.
`
`14/873,110, LADMAN, J., et al., filed October 01, 2015.
`
`a
`
`Final Office Action mailed April 18, 2016, in United States Patent Application No. 14/700,349,
`SCHWARZ T., et al., filed April 30, 2015.
`
`Final Office Action mailed December 1, 2016, in United States Patent Application No.
`14/789,658, LADMAN, J., et al., filed July 01, 2015.
`
`Final Office Action mailed January 27, 2017 in United States Patent Application No. 15/060,375,
`SCHWARZ, T., et al., filed March 3, 2016.
`
`Final Office Action mailed January 4, 2017, in United States Patent Application No. 15/073,318,
`SCHWARZ, T., et al., filed March 17, 2016.
`
`Final Office Action mailed July 1, 2016, in United States Patent Application No. 14/870,713,
`SCHWARZ, T., et al., filed September 30, 2015.
`
`Final Office Action mailed July 14, 2017, in United States Patent Application No. 15/344,811,
`SCHWARZ, T., et al., filed November 07, 2016.
`
`Final Office Action mailed June 22, 2017, in United States Patent Application No. 15/151,012,
`SCHWARZ, T., et al., filed May 10, 2016.
`
`Final Office Action mailed June 26, 2017, in United States Patent Application No. 15/099,274,
`PRIBULA, O., et al., filed April 14, 2016.
`
`Final Office Action mailed May 20, 2016, in United States Patent Application No. 14/697 ,934,
`ZARSKY,J., et al., filed April 28, 2015.
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether ornotcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. ' Applicant's unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached.
`
`

`

`Substitute for form 1449/PTO
`
`
`
`Complete if Known
`Application Number
`17/151,389
`Filing
`Dat
`[FilingDate01-18-2021
`
` First NamedInventor SCHWARZ; Tomas
`Art Unit
`3794
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`4387.0160001
`|
`| of
`4
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`Cite
`No!
`
`Include name of the author(in CAPITAL LETTERS),title of the article(when appropriate), title of
`the item (book, magazine,journal,serial,symposium, catalog, etc. ), date, page(s),volume-issue
`number(s), publisher, city and/or country where published.
`
`T2
`
`Final Office Action mailed November 4, 2016, in United States Patent Application No.
`14/951,093, SCHWARZ, T., et al., filed November 24, 2015.
`
`Final Office Action mailed August 12, 2016, in United States Patent Application No. 14/926,365,
`PROUZA, O., et al., filed 29 October 2015.
`
`Non Final Office Action mailed December 01, 2016, in United States Patent Application No.
`15/151,012, SCHWARZ,T., et al., filed May 10, 2016.
`
`Non Final Office Action mailed December 12, 2016, in United States Patent Application No.
`15/099,274, PRIBULA, O., et al., filed April 14, 2016.
`
`Non Final Office Action mailed December 17, 2015, in United States Patent Application No.
`14/697 ,934, ZARSKY,J., et al., filed April 28, 2015.
`
`Non Final Office Action mailed February 10, 2016, in United States Patent Application No.
`14/873,110, LADMAN, J., et al., filed October 01, 2015.
`
`Non Final Office Action mailed February 11, 2016, in United States Patent Application No.
`14/926,365, PROUZA, P., et al., filed October 29, 2015. .
`
`Non Final Office Action mailed February 25, 2016, in United States Patent Application No.
`14/870,713, SCHWARZ,T., et al., filed September 30, 2015.
`
`Non Final Office Action mailed June 16, 2016, in United States Patent Application No.
`15/073,318, SCHWARZ, T., et al., filed March 17, 2016. .
`
`Non Final Office Action mailed June 27, 2017 in United States Patent Application No.
`15/601,719, SCHWARZ,T., et al., filed May 22, 2017.
`
`Non Final Office Action mailed June 28, 2017, in United States Patent Application No.
`15/073,318, SCHWARZ, T., et al., filed March 17, 2016.
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether ornotcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. ' Applicant's unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached.
`
`

`

`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`5
`
`| of
`
`|
`
`
`
`
`
`Application Number
`Filing
`Dat
`
`Complete if Known
`17/151,389
`
`[FilingDate01-18-2021 First NamedInventor
`SCHWARZ; Tomas
`Art Unit
`3794
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`4387.0160001
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`Cite
`No!
`
`Include name of the author(in CAPITAL LETTERS),title of the article(when appropriate), title of
`the item (book, magazine,journal,serial,symposium, catalog, etc. ), date, page(s),volume-issue
`number(s), publisher, city and/or country where published.
`
`T2
`
`Non Final Office Action mailed June 29, 2017, in United States Patent Application No.
`14/789,156 , LADMAN, J., et al., filed July 01, 2015.
`
`Non Final Office Action mailed June 30, 2017, in United States Patent Application No.
`15/471,946, SCHWARZ, T., et al., filed March 28, 2017.
`
`Non Final Office Action mailed March 24, 2017, in United States Patent Application No.
`15/396 ,073, SCHWARZ, T., et al., filed December 30, 2016.
`
`Non final Office Action mailed March 28, 2017, in United States Patent Application No.
`15/344,811, SCHWARZ, T., et al., filed November 07, 2016.
`
`Non Final Office Action mailed May 9, 2016, in United States Patent Application No.
`14/789,658, LADMAN, J., et al., filed July 01, 2015.
`
`Non Final Office Action mailed May 9, 2016, in United States Patent Application No.
`14/951 ,093, SCHWARZ, T., et al., filed November 24, 2015. .
`
`Non Final Office Action mailed November 04, 2015, in United States Patent Application No.
`14/700,349, SCHWARZT.., et al., filed April 30, 2015.
`
`Non Final Office Action mailed May 4, 2016, in United States Patent Application No.
`14/873,110, LADMAN, J., et al., filed 01 October 2015.
`
`OBSLUZE, "Apparatus for High Induction Magnetic Stimulation," 2016, 42 pages.
`
`TriLipo MED Procedure, http://download.lifvation.com/Maximus_TriLipoMED_Intro.pdf , April
`2013, 76 pages.
`
`World Health Organization, "Neurological Disorders--Public Health Challenges", pp. 1-115
`(2006).
`
`World Health Organization, "The Atlas: Epilepsy Care in the World", pp. 1-96 (2005).
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether ornotcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. ' Applicant's unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached.
`
`

`

`Substitute for form 1449/PTO
`
`Application Number
`Filing
`Dat
`
`Complete if Known
`17/151,389
`
`
`
`[FilingDate01-18-2021 First NamedInventor
`SCHWARZ; Tomas
`Art Unit
`3794
`Examiner Name
`GILBERT, SAMUEL G
`Attorney Docket Number
`4387.0160001
`|
`| of
`6
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`
`
`Please see 37 CFR 1.97 and 1.98 to makethe appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`[]
`
`OR
`
`[]
`
`That each item of information contained in the information disclosure statement wasfirst cited in any
`communication from a foreign patentoffice in a counterpart foreign application not more than three monthsprior to
`the filing of the information disclosure statement. See 37 CFR 1.97(e)(1).
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`foreign patent office in a counterpart foreign application, and,
`to the knowledge of the person signing the
`certification after making reasonable inquiry, no item of information contained in the information disclosure
`statement was knownto anyindividual designated in 37 CFR 1.56(c) more than three months prior to the filing of
`the information disclosure statement. See 37 CFR 1.97(e)(2).
`
`[]
`
`See attached certification statement.
`
`XX] Acertification statement is not submitted herewith.
`
`[]
`
`Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`COPIES
`
`FEE
`
`[]
`
`Anidentification of an earlier application pursuant to 37 CFR 1.98 (d)(1) is attached.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for
`the form of the signature.
`
`
`
`/Richard D. Coller III/
`Richard D. Coller Ill
`
`Date (YYYY-MM-DD)
`Registration Number
`
`2024-12-30
`60,390
`
`Signature
`Name/Print
`
`23776759.1
`
`